Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Hospital Blueprint of the Future. Part 1 of 2.

The pandemic forever changed the way we engage with healthcare, but the road to change was a long time coming. While exasperated by the pandemic, the way people interact with healthcare was already big on virtual visits and connected infrastructure. The hospital of the future is already here, so what does that look like, how…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The pandemic forever changed the way we engage with healthcare, but the road to change was a long time coming. While exasperated by the pandemic, the way people interact with healthcare was already big on virtual visits and connected infrastructure. The hospital of the future is already here, so what does that look like, how do current standards react to this change, and how do new technologies keep it evolving?

On this episode of Healthcare on Air by Verizon, host Lea Sims spoke with guests Danny Johnson and Gary Lynch about the hospital of the future and what it looks like. While Johnson looks at how Verizon’s 5G technology can be used for more interconnectivity between sectors, Lynch focuses on major market trends. They understand that private networks, private 5G, edge computing, and core security are important to the new ways hospitals are running.

“Looking at what happened in the pandemic, where are providers focused? They’ve moved to being more patient centric, right?” said Lynch, regarding the vision of the hospital of the future. “I’m putting the patient at the center of the universe and kind of building their services and solutions around it. We’re moving more virtual, more care moving out of the four walls of the hospital into the home, more ambulatory.”

This episode also covers:

  • The physical and virtual environment of hospitals and healthcare
  • Changing technologies within healthcare
  • How new technology can be implemented into established legacy hospitals

Lynch noted that some hospitals remained profitable and functionable during the pandemic, thanks to going virtual. This is part of why the hospital of the future is very much the hospital of the present, as many hospitals and healthcare facilities are using this technology successfully. “This hospital of the future has kind of evolved into this really ‘ecosystem of the future,’ if you will.”

Danny Johnson is the Director of Product Marketing at Verizon, focusing on 5G, MEC, IoT, SDN, and next generation services. Gary Lynch is the Global Practice Lead of Healthcare and Life Sciences at Verizon, having first started as their Managing Partner of Global Solutions for Healthcare and Life Sciences Vertical.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Microsoft’s 60% Dragon Copilot discount forces a new way to measure digital health ROI

Microsoft’s 60% Dragon Copilot discount forces a new way to measure digital health ROI

Microsoft has introduced a 60% discount for its Dragon Copilot, prompting a reevaluation of how digital health ROI is measured. The initiative targets rural hospitals, while European efforts like EDiHTA highlight the need for a consistent method to price technology evidence. This shift reflects a broader trend in healthcare towards data-driven decision-making and cost assessment.

  • 01Microsoft offers a 60% discount for Dragon Copilot aimed at rural hospitals.
  • 02There's a growing need for a standardized approach to pricing technology evidence in healthcare.
  • 03The European EDiHTA initiative exemplifies the trend of data-driven evaluation in digital health.

Aug 30, 2026

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512